IFCC Feed 2018-03-17T19:16:10Z Insoft Feed Generator /ifcc-news/ IFCC Call for Nominations 2018-03-16T19:16:58Z /ifcc-news/2018-03-16-ifcc-call-for-nominations/ IFCC Office For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.

IFCC eNews No 2, Mar 2018 2018-03-12T15:54:47Z /ifcc-news/2018-03-12-ifcc-enews-no-2-mar-2018/ IFCC Office

IFCC eNews:  March 2018

eNews logo large globe eNews flipping
PDF version
Flip-page version
  Note for eMagStudio publications: the type-in fields for the "Search" and "Go to page" functions are not enabled in full-screen mode.

  • A new IFCC Division: the Emerging Technologies Division (ETD)
  • The IFCC Curriculum, Phase 1 – now available for download
  • Vaccination: a public health issue
  • New IFCC Distinguished Award: "Gérard SIEST-Biologie Prospective Award 2020"
  • IFCC - Task Force Young Scientists (TFYS)
  • Clinical Chemistry Trainee Council
    • In memory of Prof. Giovanni Ceriotti (SIBioC)

    • News from the Spanish Society of Laboratory Medicine (SEQCML)

    • News from Pakistan: Meeting report (PAP)

    • 2nd EFLM Strategic Conference, 18-19 June 2018, Mannheim (DE)

    • In memory of Professor Dr. Ad P. Jansen (EFLM)

  • IFCC's Calendar of Congresses, Conferences & Events


Diagnóstico in Vitro - Febrero 2017 2018-02-23T11:50:31Z /ifcc-news/2018-02-21-div-february-2018/ IFCC Office Auspiciado por la Federación Internacional de Química Clínica, "Diagnóstico in Vitro" es un nexo de unión entre los países Latinoamericanos, Portugal y España, que contribuye a difundir temas científicos a través de Internet, facilitando el conocimiento de publicaciones y temas de interés comunes a las ciencias del laboratorio clínico.


Cover PDF.jpg Cover Flip.jpg

Click here to access the PDF version
Haga clic aquí para acceder la versión PDF

Click here to access the Flip version
Haga clic aquí para acceder la versión Flip



The IFCC Curriculum is now available for download 2018-02-19T10:41:54Z /ifcc-news/2018-02-19-ifcc-curriculum/ IFCC Office A laboratory medicine expert is expected to have a comprehensive knowledge of the science and medicine on which the specialty is based and to use this knowledge to develop a safe, effective, efficient and high quality service to its users. The IFCC Curriculum was developed as part of the IFCC eAcademy project by the Committee for Distance Learning and is designed to guide the development of eAcademy content and to provide a framework of learning both practical and theoretical components through which this expertise can be achieved.

Version 1 of the curriculum, now available, addresses concepts related to Laboratory Organisation and Management and Blood Sciences (Clinical Chemistry and Immunology). Future additions to the curriculum will expand the scope to other disciplines within laboratory medicine.

Click here to download the IFCC Curriculum


IFCC Call for Nominations 2018-02-19T11:11:04Z /ifcc-news/2018-02-16-ifcc-call-for-nominations/ IFCC Office For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.

IFCC eNews No 1, Feb 2018 2018-02-19T12:23:54Z /ifcc-news/2018-02-01-ifcc-enews-no-1-feb-2018/ IFCC Office

IFCC eNews:  February 2018

eNews logo large globe eNews flipping
PDF version
Flip-page version
  Note for eMagStudio publications: the type-in fields for the "Search" and "Go to page" functions are not enabled in full-screen mode.


  • Welcome message from the IFCC President

  • IFCC eNews to be published ten times per year

  • Successful 14th International Congress of Paediatric Laboratory Medicine in Durban

  • Poster awards at IFCC WorldLab 2017 Durban

  • How can you explain traceability in laboratory medicine to your clinician users?

  • Accreditation of medical laboratories – success for the 50% cap


♦ News from France (SFBC): National Congress on advances in cancer biology

♦ News from Mexico (CMCLC): 2nd Regional Symposium of Diabesity

♦ News from Pakistan: guest lecture on diagnosis of lysosomal storage diseases

♦ Greetings from the new EFLM President

♦ EFLM Executive Board 2018-2019

♦ Updates to the EFLM publication list

♦ The XI Uruguayan Congress of Clinical Biochemistry


  • IFCC's Calendar of Congresses, Conferences & Events

IFCC TF-YS Webinar onIntegration and Impact of High-Sensitive Troponin Testing in Improving Patient Care 2018-02-12T10:45:03Z /ifcc-news/2018-02-15-ifcc-tf-ys-free-webinar/ IFCC Office This educational program focuses on highly sensitive Troponin assays that have been recently introduced in Europe

Click here for further information and to register to the complimentary webinarTF YS Logo


Emerging Technologies - a new IFCC Division 2018-01-31T14:00:47Z /ifcc-news/2018-02-01-ifcc-etd/ IFCC Office The creation of this new unit has its scope in having a role in reviewing the emerging technologies in Laboratory Medicine as Cancer NGS Metabolomics (with special attention to Big Data elaboration and Omics integration), implantable diagnostic tools, LabMed in Digital Health Systems. 

The Executive Board has appointed Prof. Sergio Bernardini, as ETD Chair. 

Members of the ETD are:

Paolo Fortina            Vice-Chair                   US      

Ronda Greaves          Secretary                    AU

Damien Gruson          Member                      BE      

Markus Roessler         Corporate Member       DE      

Peng Yin                    Corporate Member       US


For more information, visit the ETD page 

Participate in the C-CLM Survey on Leadership! 2018-01-30T13:20:14Z /ifcc-news/2018-01-30-c-clm-survey-on-leadership/ IFCC Office C-CLM is developing a Laboratory Leadership Training Program that can be used by Clinical Laboratory Leaders to improve their leadership techniques and skills. We would like to assess the practice patterns and opinions of all clinical or medical laboratory professionals through a survey.

The survey is not meant to be a competency assessment, but will be used to identify learning needs and preferences for developing a high-quality laboratory leadership training program that will be of value to the members of IFCC National Societies.

To participate in the survey, please go to: 


For more information on C-CLM and its activities visit C-CLM web-page

IFCC President Message 2018-01-26T08:48:30Z /ifcc-news/2018-01-24-ifcc-president-message/ IFCC Office It is a great pleasure to present my welcoming message to all our national society and corporate member colleagues. It is your expertise and dedication to improve health outcomes for patients and communities that are the greatest strengths of the IFCC.  I very much look forward to working closely with you and together facing the opportunities and challenges for laboratory medicine over this next period. It is your expertise which gives me great confidence that we will continue to develop the quality and performance of laboratory medicine to meet the future needs of our patients and the healthcare system.

Laboratory medicine currently faces significant challenges some of which confront all the healthcare disciplines. However we face particular issues arising from the perception of laboratory medicine as merely a service provider rather than a driver for optimal healthcare. Clinical laboratories are being required to assume increased responsibilities for service provision and patient safety with ever decreasing budgets. Financial constraints also impact our corporate members, moderating their ability to collaborate in professional development and, at the same time, the academic basis of laboratory medicine is diminishing.

Professional leadership has never been more vital to provide strategies for improving the crucial role of laboratory medicine in patient care. Such leadership is provided by the IFCC, our regional federations and our national societies. We work in this field together and each of our organizations plays an essential role at the different levels of engagement. Clearly communication is critical and the interactions between the IFCC and the regional federations will now be markedly enhanced with the inclusion of representatives of each of the regional federations on the IFCC Executive Board. The IFCC General Conference, this year being held in November, provides further opportunity between the national society representatives, regional federations and IFCC Officers to engage in discussions and debate on the key issues currently facing laboratory medicine.

As President I look forward to extending the work of the IFCC in a range of important areas.

Technologies relevant to clinical laboratory practice are rapidly emerging from academic and industry research laboratories and being adopted by highly specialized scientists within clinical laboratories. But their full benefits for patient care cannot be realized until they are translated to areas capable of high-throughput processing for medical tests and meeting performance criteria for accreditation purposes. The Emerging Technologies Division (ETD) is a new addition to the IFCC functional units and is responsible for identifying and assessing emerging technologies and translating the emerging and disruptive diagnostic and data analysis procedures from academic laboratories to clinical laboratories and from clinical laboratories to routine practice.

Improving clinical laboratory performance through standardization and traceability as it impacts on the rational use of clinical laboratory resources continues to be a major focus of the Scientific Division. This work will be enhanced by the IFCC hosting the International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) which will improving the close working relationships between IFCC, ICHCLR and the Joint Committee for Traceability in Laboratory medicine (JCTLM) during the next triennium. A major challenge is to extend these activities to regions in which the current multi-national In-Vitro Diagnostic industry members are not necessarily the major providers of clinical laboratory instruments and reagents, such as in the Asia Pacific and Central and South American regions. Major achievements have been made in this field only with the close collaboration of the IFCC with relevant institutions in Europe (European Commission - Joint Research Centre) and the USA (National Institute of Science and Technology). During 2018 these collaborations will extend to China (National Institute for Food and Drug Control). We look forward to continuing this important work in collaboration with these important institutions.

IFCC educational and training activities capable of meeting the needs of both developing and developed communities across general laboratory medicine subjects, specialised services and clinical laboratory management have long been a high priority for IFCC. It is most gratifying that this work will be enhanced through the joint efforts of the Education and Management Division and Communications and Publications Division with the promotion of eLearning facilities and opportunities. These electronic resources will be available to clinical laboratory practitioners around the world with internet access.

As discussed above laboratory medicine faces particular challenges and it is important that as a profession we improve our ability to present a coherent strategy to our clinical colleagues, to healthcare managers and those paying for medical tests such as insurers and governments.  Closer interactions between international organisations representing the various disciplines of laboratory medicine will greatly assist common engagement by our profession with these stakeholders. Of particular interest in these collaborations will be value of medical tests in order to demonstrate to all stakeholders in healthcare that laboratory medicine can be a a driver of optimal and financially sustainable healthcare delivery.

I look forward to working directly with many of you over the next triennium and particularly hope we can meet at the IFCC General Conference being held in Budapest in November. I welcome any suggestions to improve our organization and activities.


Best wishes,

Prof. Howard Morris

IFCC President